Stone X Group Inc. Abbott Laboratories Transaction History

Stone X Group Inc.

$2.06 Trillion
Q2 2025

A detailed history of Stone X Group Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Stone X Group Inc. holds 20,649 shares of ABT stock, worth $2.78 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

20,649

Holding current value

$2.78 Million

% of portfolio

0.14%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$123.95 - $138.08 $2.56 Million - $2.85 Million	20,649 New	20,649 $2.81 Billion
Q1 2025 Aug 13, 2025	BUY	$111.1 - $140.22 $96,657 - $121,991	870 Added 4.18%	21,681 $2.88 Billion
Q1 2025 May 15, 2025	BUY	$111.1 - $140.22 $159,428 - $201,215	1,435 Added 7.09%	21,681 $2.88 Million
Q4 2024 Aug 13, 2025	BUY	$111.93 - $119.39 $668,222 - $712,758	5,970 Added 40.23%	20,811 $2.35 Billion
Q4 2024 Feb 12, 2025	BUY	$111.93 - $119.39 $820,558 - $875,248	7,331 Added 56.76%	20,246 $2.29 Million
Q3 2024 Aug 13, 2025	BUY	$100.07 - $118.13 $319,623 - $377,307	3,194 Added 27.42%	14,841 $1.69 Billion
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $126,888 - $149,788	1,268 Added 10.89%	12,915 $1.47 Million
Q2 2024 Aug 13, 2025	SELL	$100.73 - $112.44 $1.01 Million - $1.13 Million	-10,034 Reduced 46.28%	11,647 $1.21 Billion
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $128,531 - $143,473	1,276 Added 12.3%	11,647 $1.21 Million
Q1 2024 Aug 13, 2025	BUY	$109.52 - $120.96 $299,646 - $330,946	2,736 Added 35.83%	10,371 $1.18 Billion
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $1.14 Million - $1.25 Million	10,371 New	10,371 $1.18 Million
Q4 2023 Aug 13, 2025	SELL	$90.19 - $110.4 $1.27 Million - $1.55 Million	-14,046 Reduced 64.78%	7,635 $840 Million
Q3 2023 Aug 13, 2025	BUY	$95.53 - $114.62 $53,592 - $64,301	561 Added 7.4%	8,143 $789 Million
Q2 2023 Aug 13, 2025	SELL	$100.78 - $112.29 $1.42 Million - $1.58 Million	-14,099 Reduced 65.03%	7,582 $827 Million
Q1 2023 Aug 13, 2025	BUY	$96.86 - $114.01 $370,876 - $436,544	3,829 Added 70.17%	9,286 $940 Million
Q4 2022 Aug 13, 2025	SELL	$95.06 - $111.52 $1.54 Million - $1.81 Million	-16,224 Reduced 74.83%	5,457 $599 Million
Q3 2022 Aug 13, 2025	SELL	$96.76 - $112.03 $141,946 - $164,348	-1,467 Reduced 19.95%	5,887 $570 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $51,476 - $59,599	532 Added 10.02%	5,842 $565,000
Q2 2022 Aug 13, 2025	BUY	$102.07 - $123.37 $166,680 - $201,463	1,633 Added 28.54%	7,354 $799 Million
Q2 2022 Jul 27, 2022	BUY	$102.07 - $123.37 $541,991 - $655,094	5,310 New	5,310 $577,000
Q1 2022 Aug 13, 2025	SELL	$114.02 - $139.04 $1.82 Million - $2.22 Million	-15,960 Reduced 73.61%	5,721 $677 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $727,333 - $886,936	-6,379 Closed	0 $0
Q4 2021 Aug 13, 2025	SELL	$115.53 - $141.46 $1.77 Million - $2.16 Million	-15,302 Reduced 70.58%	6,379 $897,000
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $63,194 - $77,378	547 Added 9.38%	6,379 $898,000
Q3 2021 Oct 20, 2021	BUY	$116.66 - $129.06 $91,344 - $101,053	783 Added 15.51%	5,832 $689,000
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $62,627 - $73,721	592 Added 13.28%	5,049 $585,000
Q1 2021 Jun 23, 2021	SELL	$108.84 - $128.23 $3,700 - $4,359	-34 Reduced 0.76%	4,457 $534,000
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $1,785 - $1,945	-17 Reduced 0.38%	4,491 $491,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $72,945 - $88,586	796 Added 21.44%	4,508 $490,000
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $57,963 - $74,186	757 Added 25.62%	3,712 $339,000
Q1 2020 Apr 30, 2020	BUY	$62.82 - $91.86 $185,633 - $271,446	2,955 New	2,955 $233,000
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $205,023 - $228,828	-4,266 Closed	0 $0
Q2 2017 Aug 31, 2017	BUY	N/A	4,266	4,266 $207,000

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account